9
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Adult-onset muscle weakness

How to identify the underlying cause

Pages 217-226 | Published online: 16 May 2016

References

  • Brooke MH. A clinician's view of neuromuscular diseases. Baltimore: Williams & Wilkins. 1977
  • Medical Research Council. Aids to the examination of the peripheral nervous system. London: Her Majesty's Stationery Office. 1976
  • Kuller LH. Epidemiology of stroke in: Schoenberg BS. ed. Neurological epidemiology: principles and clinical applications New York: Raven Press. 1978: 281–310 (Advances In neurology series, vol 19)
  • Mulder DW. Clinical limits of amyotrophic lateral sclerosis. In: Rowland LP, ed. Human motor neuron diseases. New York: Raven Press, 1982: 15–22 (Advances in neurology series, vol 36)
  • Kurtzke JF. Epidemiology of amyotrophic lateral sclerosis. In: Rowland, ed. 4 pp 281–302
  • Juergens SM, Kurland LT, Okazaki H, et al. ALS in Rochester. Minnesota. 1925–1977. Neurology (NY) 1980: 30(5): 463–70
  • Schaumburg HH, Spencer PS, Thomas PK. The Inflammatory polyneuropathies (Guillain-Barré syndrome and related disorders). In: Schaumbuig HH. et al. Disorders of peripheral nerves. Philadelphia: FA Davis, 1983: 25–39 (Contemporary neurology series. No. 24)
  • Asbury AK. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol 1981: 9(Suppl): 1–5
  • Schoenberg BS. Epidemiology of Guillaln-Barrée syndrome. In: Schoenberg, ed,3 pp 249–58
  • Kaplan JE, Schonberger LB, Hurwitz ES, et al. Guillain-Barré syndrome in the United States. 1978–1981: additional observations from the national surveillance system. Neurology (NY) 1983: 33(5): 633–7
  • Hughes RA, Kadlubowski M, Hufschmidt A. Treatment of acute inflammatory polyneuropathy. Ann Neurol 1981: 9(Suppl): 125–33
  • Simpson JA. Myasthenia gravis: a personal view of pathogenesis and mechanism. Muscle Nerve 1978: 1(1): 45–56: 1978: 1(2): 151–6
  • Kurtzke JF. Epidemiology of myasthenia gravis. In: Schoenberg. ed.3 pp 545–64
  • Drachmen DB. Myasthenia gravis. N Engl J Med 1978: 298(3): 136–42: 1978: 298(4): 186–93
  • Rlggs JE. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis. Clin Neuro-pharmacol 1982: 5(3): 277–92
  • Patten BM. Myasthenia gavis: review of diagnosis and management. Muscle Nerve 1978: 1(3): 190–205
  • Whitaker JN. Inflammatory myopathy: a review of etiologic and pathogenetic factors. Muscle Nerve 1982: 5(8): 573–92
  • Rowland LP, Clark C, Olarte M. Therapy for dermatomyosltls and polymyositis. In: Griggs RC. Moxley RT. eds. Treatment of neuromuscular diseases. New York: Raven Press, 1977: 63–97 (Advances In neurology series, vol 17)
  • Bohan A, Peter JB, Bowman RL, et al. Computerassisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977: 56(4): 255–86
  • Carpenter S, Karpati G, Heller L et al. Inclusion body myositis: a distinct variety of Idiopathic inflammatory myopathy. Neurology (NY) 1978: 28(1): 8–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.